$123.8M worth of BOD Performance - You make the call
posted on
Jan 12, 2010 01:31PM
Below are the PTSC balance sheets for May '05 at the time of the merger with TPL, for May '07 when the company KNEW that the patents would face reexamination, and for this last 10q period.
Over that time, PTSC has received $123.8M total from MMP revenue. Since May of '07, when it was absolutely clear they faced a USPTO battle, they have received $34.7M in MMP revenue.
IMO, the balance sheet is the clearest and most unbiased reflection of what they've accomplished. Essentially, the bottom line is that they've taken in $123.8M and increased the company's total assets by $25.6M since May of 2005.
Is $25.6M in return for $123.8M an acceptable measure of performance? IMO, this should be considered in the context that as of May 2005 there was a staff of less than 10 people at PTSC, and almost 5 years later, we now are questioning whether any of our assets aside from the MMP have any signifcant value moving forward.
Where did the other $98M go to? Who benefitted from the additional 130M outstanding shares that came about during that time period? Is it acceptable that we sit at the same price per share today, that we did at the end of FY2005? Is this acceptable in light of the BOD having switched CEO's 4 times during that period?
Perhaps I'm being unreasonable, but I find this performance deplorable. And in the context of where we were in 2005 with very little overhead, and where we are now, and realizing the only non-self-inflicted problem is in the re-exams, it is doubly so.
Unfortunately, it appears as though this BOD thinks that this performance IS acceptable, as while they continue to make changes, despite change after change over the last 5 years, their performance hasn't improved, but yet they refuse to recuse themselves. They are the ONE CONSTANT.
While I can't make it to SHM in Chicago, as I'm sure is their biggest reason for having it there (to make it difficult to face shareholders in general - not me specifically), I hope those who are able to make it, will hold this BOD to answer for this balance sheet.
Current | Re-Exams Underway | At Time of Merger | ||||
11/30/2009 | 5/30/2007 | 5/30/2005 | ||||
ASSETS
|
||||||
Current assets:
|
||||||
Cash and cash equivalents
|
$ 11,573,153 |
$ 21,605,428
|
$ 591,426
|
|||
Restricted cash and cash equivalents
|
$ 20,654 |
$ 102,346
|
$ 201,648 | |||
Marketable securities and short term investments
|
$ 379,486 |
$ 4,349,314
|
$ 697,524
|
|||
Accounts receivable
|
$ 19,440 |
$ 352,390
|
$ 2,000,000
|
|||
Accounts receivable - affiliate company
|
$ 503,333 | |||||
Inventory/Work In Progress
|
$ 65,253 |
$ 46,361
|
||||
Prepaid income taxes
|
$ 199,699 |
$ 2,070,981
|
||||
Current Portion of Deferred tax assets
|
$ 137,912 |
$ 2,439,975
|
||||
Prepaid expenses and other current assets
|
$ 175,653 |
$ 431,840
|
$ 121,758
|
|||
Total current assets
|
$ 13,074,583 | $ 31,398,635 | $ 3,612,356 | |||
Property and equipment, net
|
$ 120,890 |
$ 85,518
|
$ 21,376
|
|||
Marketable securities
|
$ 7,393,878 | |||||
Other assets
|
$ 8,190
|
$ 23,891
|
||||
Goodwill
|
$ 642,981 | |||||
Investment in affiliated company
|
$ 435,182
|
$ 2,883,969
|
||||
Other intangible assets, net
|
$ 1,860,000 | |||||
Other assets
|
$ 41,608 | |||||
Deferred Tax Assets
|
$ 5,763,805 | |||||
Patents and trademarks
|
$ 38,317
|
$ 66,411
|
||||
Total Assets | $ 29,332,927 | $ 34,414,629 | $ 3,724,034 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||
Current liabilities:
|
||||||
Line of Credit
|
$ 100,000
|
|||||
Current Portion of Debentures | $ 421,847 | |||||
Current Portion of Lease Obligation | $ 2,306 | |||||
Accounts payable
|
$ 198,267 |
$ 934,298
|
$ 268,458
|
|||
Accrued expenses and other
|
$ 616,374 |
$ 1,086,496
|
$ 346,000
|
|||
Accrued contested fee | $ 505,153 | |||||
Deferred revenue
|
$ 20,116 |
-
|
-
|
|||
Total current liabilities
|
$ 834,757 | $ 2,020,794 | $ 1,643,764 | |||
Convertible Debentures
|
$ 45,942 | |||||
Distributions in excess of investment in affiliated company
|
$ 151,494 | |||||
Long term debt, including accrued interest
|
$ 3,081,846 | |||||
Deferred tax liabilities
|
$ 12,222,944
|
|||||
Total long term liabilities
|
$ 3,233,340 | $ 12,222,944 | $ 45,942 | |||
Total liabilities
|
$ 4,068,097 | $14,243,738 | $ 1,689,706 | |||
Commitments and contingencies
|
||||||
Stockholders’ equity
|
||||||
Preferred stock, $.00001 par value; 5,000,000 shares authorized: none outstanding
|
-
|
-
|
-
|
|||
Common stock
|
$ 4,380 |
$ 4,066
|
$ 2,805
|
|||
Additional paid-in capital
|
$ 77,156,258 |
$ 72,150,581
|
$ 54,569,091
|
|||
Accumulated deficit
|
$ (37,613,548) |
$ (43,151,678)
|
$ (52,537,568)
|
|||
Accumulated other comprehensive loss
|
$ (391,366) | |||||
Common stock held in treasury, at cost - 13,467,527 shares and no shares at May 31, 2007 and 2006, respectively
|
$ (13,890,894)
|
$ (8,832,078)
|
||||
Total stockholders’ equity
|
$ 25,264,830 | $ 20,170,891 | $ 2,034,328 | |||
$ 29,332,927 | $ 34,414,629 | $ 3,724,034 | ||||
Total Shares Outstanding |
410,093,076
|
393,201,134
|
280,492,013 | |||
PPS at close of period | $0.18 | $0.51 | $0.14 | |||
Market Cap | $ 73,816,753.68 | $200,532,578.34 | $ 39,268,881.82 |